Cargando…

Prognostic and biological role of the N-Myc downstream-regulated gene family in hepatocellular carcinoma

BACKGROUND: The N-Myc downstream-regulated gene (NDRG) family is comprised of four members (NDRG1-4) involved in various important biological processes. However, there is no systematic evaluation of the prognostic of the NDRG family in hepatocellular carcinoma (HCC). AIM: To analyze comprehensively...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yin, Xin, Yu, Hao, He, Xing-Kang, Yan, Sen-Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Clinical and Translational Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895174/ https://www.ncbi.nlm.nih.gov/pubmed/35321174 http://dx.doi.org/10.12998/wjcc.v10.i7.2072

Ejemplares similares

Solute carrier family 2 members 1 and 2 as prognostic biomarkers in hepatocellular carcinoma associated with immune infiltration
por: Peng, Qing, et al.
Publicado: (2022)

N-myc downstream-regulated gene 1: Diverse and complicated functions in human hepatocellular carcinoma (Review)
por: SONG, YAN, et al.
Publicado: (2013)

Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular Carcinoma
por: Chamseddine, Shadi, et al.
Publicado: (2023)

Effect of prior malignancy on the prognosis of gastric cancer and somatic mutation
por: Yin, Xin, et al.
Publicado: (2022)

Differential expression and hypoxia‐mediated regulation of the N‐myc downstream regulated gene family
por: Le, Nguyet, et al.
Publicado: (2021)

Differences of core genes in liver fibrosis and hepatocellular carcinoma: Evidence from integrated bioinformatics and immunohistochemical analysis
por: Li, Yue, et al.
Publicado: (2022)

Nervous NDRGs: the N-myc downstream–regulated gene family in the central and peripheral nervous system
por: Schonkeren, Simone L., et al.
Publicado: (2019)

N-myc downstream-regulated gene 1 inhibits the proliferation and invasion of hepatocellular carcinoma cells via the regulation of integrin β3
por: Song, Yan, et al.
Publicado: (2017)

Potential role of the N-MYC downstream-regulated gene family in reprogramming cancer metabolism under hypoxia
por: Lee, Ga Young, et al.
Publicado: (2016)

N-myc downstream regulated gene 1 inhibition of tumor progression in Caco2 cells
por: He, Yi-Xiao, et al.
Publicado: (2022)

Association and prognostic significance of alpha-L-fucosidase-1 and matrix metalloproteinase 9 expression in esophageal squamous cell carcinoma
por: Yu, Xiang-Yang, et al.
Publicado: (2022)

Expression patterns of cluster of differentiation 147 impact the prognosis of hepatocellular carcinoma
por: Xu, Yun-Ji, et al.
Publicado: (2023)

MYC oncogene is associated with suppression of tumor immunity and targeting Myc induces tumor cell immunogenicity for therapeutic whole cell vaccination
por: Wu, Xiaofang, et al.
Publicado: (2021)

Exploring the pharmacological mechanism of Wuzhuyu decoction on hepatocellular carcinoma using network pharmacology
por: Ouyang, Jia-Ying, et al.
Publicado: (2023)

Clinical relevance of increased serum preneoplastic antigen in hepatitis C-related hepatocellular carcinoma
por: Yamashita, Satoyoshi, et al.
Publicado: (2020)

The Expression and Localization of N-Myc Downstream-Regulated Gene 1 in Human Trophoblasts
por: Shi, Xiao-Hua, et al.
Publicado: (2013)

Clinical and prognostic significance of expression of phosphoglycerate mutase family member 5 and Parkin in advanced colorectal cancer
por: Wu, Can, et al.
Publicado: (2022)

N-myc downstream-regulated gene 2 expression is associated with glucose transport and correlated with prognosis in breast carcinoma
por: Ma, Ji, et al.
Publicado: (2014)

Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma
por: Li, Bing, et al.
Publicado: (2014)

N-myc downstream regulated gene 1 modulates Wnt-β-catenin signalling and pleiotropically suppresses metastasis
por: Liu, Wen, et al.
Publicado: (2012)

Cellular senescence throws new insights into patient classification and pharmacological interventions for clinical management of hepatocellular carcinoma
por: Wang, Hou-Hong, et al.
Publicado: (2023)

The Prognostic Role of MYC Structural Variants Identified by NGS and FISH in Multiple Myeloma
por: Sharma, Neeraj, et al.
Publicado: (2021)

Viral status, immune microenvironment and immunological response to checkpoint inhibitors in hepatocellular carcinoma
por: Ho, Won Jin, et al.
Publicado: (2020)

Neurotrophic receptor tyrosine kinase family members in secretory and non-secretory breast carcinomas
por: Stravodimou, Athina, et al.
Publicado: (2022)

N-Myc downstream-regulated gene 2 is involved in p53-mediated apoptosis
por: Liu, Na, et al.
Publicado: (2008)

Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer
por: Zhao, Huadong, et al.
Publicado: (2008)

Emerging role of N-myc downstream-regulated gene 2 (NDRG2) in cancer
por: Hu, Wei, et al.
Publicado: (2015)

PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice
por: Shen, B, et al.
Publicado: (2012)

Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection
por: Fu, Yi-Peng, et al.
Publicado: (2016)

The iron chelator Dp44mT inhibits hepatocellular carcinoma metastasis via N-Myc downstream-regulated gene 2 (NDRG2)/gp130/STAT3 pathway
por: Wang, Jiabei, et al.
Publicado: (2014)

Prognostic value of tumor-associated N1/N2 neutrophil plasticity in patients following radical resection of pancreas ductal adenocarcinoma
por: Chen, Qiangda, et al.
Publicado: (2022)

Oncogenic but non-essential role of N-myc downstream regulated gene 1 in the progression of esophageal squamous cell carcinoma
por: Wei, Wei, et al.
Publicado: (2013)

MYC suppresses STING-dependent innate immunity by transcriptionally upregulating DNMT1 in triple-negative breast cancer
por: Wu, Si-Yu, et al.
Publicado: (2021)

Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer
por: Chang, Q, et al.
Publicado: (2008)

Dasatinib synergises with irinotecan to suppress hepatocellular carcinoma via inhibiting the protein synthesis of PLK1
por: Xu, Li, et al.
Publicado: (2017)

Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study
por: Fessas, Petros, et al.
Publicado: (2020)

Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts
por: Chiu, M, et al.
Publicado: (2014)

Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death
por: Li, Sainan, et al.
Publicado: (2017)

Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets
por: Morera, Daley S, et al.
Publicado: (2017)

Low expression of N-myc downstream-regulated gene 2 in oesophageal squamous cell carcinoma correlates with a poor prognosis
por: Cao, Wei, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ps6osvjags3ni5r70cjvg6pbhh